SRINIVAS AKKARAJU Insider Trading $ICPT INTERCEPT PHARMACEUTICALS, INC.
Get free email notifications about insider trading for SRINIVAS AKKARAJU.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SRINIVAS AKKARAJU. SRINIVAS AKKARAJU is Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in aTYR PHARMA INC ($LIFE) and Director in ADURO BIOTECH, INC. ($ADRO) and Director in ZS Pharma, Inc. ($ZSPH) and Director in Principia Biopharma Inc. ($PRNB) and Director in Versartis, Inc. ($VSAR) and Director in Syros Pharmaceuticals, Inc. ($SYRS) and Director in Jiya Acquisition Corp. ($JYAC).
SRINIVAS AKKARAJU in INTERCEPT PHARMACEUTICALS, INC.
Trading Symbol: ICPTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SRINIVAS AKKARAJU: Director
Holdings: 477,129 shares
Current Value: $54,187,541
Latest Transaction: Mar 12 2021
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of SRINIVAS AKKARAJU in INTERCEPT PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARAV, LIFE, ADRO, ICPT, JYAC, PRNB, SGEN, SYRS, ZSPH
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 12 2021 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Buy | P | 21.29 | 147,000 | 3,129,630 | 640,688 | 493.7 K to 640.7 K (+29.78 %) |
Mar 12 2021 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Buy | P | 21.55 | 16,559 | 356,846 | 493,688 | 477.1 K to 493.7 K (+3.47 %) |
Mar 12 2021 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Buy | P | 20.83 | 73,441 | 1,529,776 | 477,129 | 403.7 K to 477.1 K (+18.19 %) |
Jun 01 2020 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 72.74 | 2,966 | 215,747 | 2,966 | |
Jun 01 2020 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 1,595 | 0 | 23,121 | 21.5 K to 23.1 K (+7.41 %) |
Aug 30 2019 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Buy | P | 60.32 | 5,207 | 314,086 | 403,688 | 398.5 K to 403.7 K (+1.31 %) |
Aug 22 2019 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Grant | A | 64.30 | 1,180 | 75,874 | 398,481 | 397.3 K to 398.5 K (+0.30 %) |
Aug 22 2019 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Grant | A | 67.12 | 29,000 | 1,946,480 | 397,301 | 368.3 K to 397.3 K (+7.87 %) |
Aug 22 2019 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Grant | A | 65.85 | 37,604 | 2,476,223 | 368,301 | 330.7 K to 368.3 K (+11.37 %) |
Jun 21 2019 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 82.25 | 2,174 | 178,812 | 2,174 | |
Jun 21 2019 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 1,570 | 0 | 21,526 | 20 K to 21.5 K (+7.87 %) |
May 14 2019 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Grant | A | 83.50 | 119,760 | 9,999,960 | 330,697 | 210.9 K to 330.7 K (+56.78 %) |
Apr 29 2019 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Option Exercise | M | 31.90 | 1,001 | 31,932 | 979 | |
Apr 29 2019 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Option Exercise | M | 21.50 | 2,499 | 53,729 | 0 | |
Apr 29 2019 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Buy | M | 31.90 | 1,001 | 31,932 | 19,956 | 19 K to 20 K (+5.28 %) |
Apr 29 2019 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Buy | M | 21.50 | 2,499 | 53,729 | 18,955 | 16.5 K to 19 K (+15.19 %) |
Feb 21 2019 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Sell | S | 128.78 | 23,438 | 3,018,346 | 210,937 | 234.4 K to 210.9 K (-10.00 %) |
Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 85.12 | 2,748 | 233,910 | 2,748 | |
Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 1,787 | 0 | 16,456 | 14.7 K to 16.5 K (+12.18 %) |
Apr 09 2018 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Grant | A | 64.00 | 234,375 | 15,000,000 | 234,375 | 0 to 234.4 K |
Jun 29 2017 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 122.01 | 2,036 | 248,412 | 2,036 | |
Jun 29 2017 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 1,423 | 0 | 14,669 | 13.2 K to 14.7 K (+10.74 %) |
Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 145.22 | 1,598 | 232,062 | 1,598 | |
Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 1,204 | 0 | 13,246 | 12 K to 13.2 K (+10.00 %) |
May 17 2016 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Option Exercise | M | 21.50 | 1,500 | 32,250 | 2,499 | |
May 17 2016 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Buy | M | 21.50 | 1,500 | 32,250 | 12,042 | 10.5 K to 12 K (+14.23 %) |
Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 183.62 | 1,750 | 321,335 | 1,750 | |
Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 650 | 0 | 10,542 | 9.9 K to 10.5 K (+6.57 %) |
Oct 30 2015 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Option Exercise | M | 21.50 | 1,250 | 26,875 | 3,999 | |
Oct 30 2015 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Buy | M | 21.50 | 1,250 | 26,875 | 9,892 | 8.6 K to 9.9 K (+14.46 %) |
May 22 2015 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Option Exercise | M | 21.50 | 1,000 | 21,500 | 5,249 | |
May 22 2015 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Buy | M | 21.50 | 1,000 | 21,500 | 8,642 | 7.6 K to 8.6 K (+13.09 %) |
Page: 1